EDP Sciences logo
Rechercher
Menu
Tous les numéros Volume 24 / Numéro 3 (2012) Ann Toxicol Anal, 24 3 (2012) 113-118 Références
Open Access
Review
Numéro
Ann Toxicol Anal
Volume 24, Numéro 3, 2012
Page(s) 113 - 118
DOI https://doi.org/10.1051/ata/2012020
Publié en ligne 12 décembre 2012
  1. Krikorian A. Khat and its use : An historical perspective. J Ethnopharmacol 1984; 12 : 115–178. [CrossRef] [PubMed] [Google Scholar]
  2. Kalix P. Catha edulis, a plant that has amphetamine effects. Pharm World Sci 1996; 18 : 69–73. [CrossRef] [PubMed] [Google Scholar]
  3. European monitoring centre for drugs and drug addiction. Khat use in Europe : implications for European policy. Drug in Focus 2011; 21. [Google Scholar]
  4. Klein A, Beckerleg S, Hailu D. Regulating khat-dilemmas and opportunities for the internal drug control system. Int J Drug Policy 2009; 20 : 509–513. [CrossRef] [PubMed] [Google Scholar]
  5. Griffiths P, Lopez D, Sedefov R, Gallegos A, Hughes B, Noor A, Royuela L. Khat use and monitoring drug use in Europe : The current situation and issue for the future. J Ethnopharmacol 2010; 132 : 578–583. [CrossRef] [PubMed] [Google Scholar]
  6. World health organization. WHO Expert Committee on Drug Dependence, 34th report. Geneva, 2006. [Google Scholar]
  7. Advisory Council on the Misuse of Drugs. Khat (Qat) : Assessment of risk to the individual and communities in the UK. London, 2005. [Google Scholar]
  8. Pennings E, Opperhuizen A, van Amsterdam J. Risk assessment of khat use in the Netherlands : a review based on adverse health effects, prevalence, criminal involvement and public order. Regul Toxicol and Pharm 2008; 52(3) : 199–207. [CrossRef] [Google Scholar]
  9. Al-Motarreb A, Al-Habori M, Broadley K. Khat chewing, cardiovascular diseases and other internal medical problems : The current situation and directions for future research. J Ethnopharmacol 2010; 132 : 540–548. [CrossRef] [PubMed] [Google Scholar]
  10. Geisshüsler S, Brenneisen R. The content of psychoactive phenylpropyl and phenylpentenyl khatamines in Catha edulis Forsk of different origin. J Ethnopharmacol 1987; 19(3) : 269–277. [CrossRef] [PubMed] [Google Scholar]
  11. Sauniers M, Cirimele V, Kintz P, Tracqui A, Ludes B. Dosage des alcaloïdes d’un plant de khat (Catha edulis Forsk) par CPG-SM. Toxicorama 1998; 10(2) : 95–97. [Google Scholar]
  12. Cox G, Rampes H. Adverse effects of khat : a review. Adv Psychiatr Treat 2003; 9 : 456–463. [CrossRef] [Google Scholar]
  13. Deveaux M, Pépin G. Dosage de la cathinone et de la cathine dans les feuilles de khat (Catha edulis) saisies. Le khat pose-t-il un nouveau problème d’addiction. Ann Toxicol Anal 2006; 18(1) : 77–83. [CrossRef] [Google Scholar]
  14. Kalix P. Pharmacological properties of the stimulant khat. Pharmacol Therapeut 1990; 48(3) : 397–416. [CrossRef] [Google Scholar]
  15. Nencini P, Ahmed A, Elm I. Subjective effects of khat chewing in humans, Drug Alcohol Depen 1986; 18(1) : 97–105. [CrossRef] [Google Scholar]
  16. Patel N. Mechanism of action of cathinone : the active ingredient of khat (Catha edulis). East Afr Med J 2000; 77 : 329–332. [PubMed] [Google Scholar]
  17. Yousef G, Huq Z, Lambert T. Khat chewing as a cause of psychosis. Br J Hosp Med 1994; 54 : 322–326. [Google Scholar]
  18. Toennes S, Harder S, Schramm M, Niess C, Kauert G. Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves, Brit J Clin Pharmacol 2003; 56(1) : 125–130. [CrossRef] [Google Scholar]
  19. Widler P, Mathys K, Brenneisen R, Kalix P, Fisch H. Pharmacodynamics and pharmacokinetics of khat : a controlled study. Clin Pharmacol Ther 1994; 55(5) : 556–562. [CrossRef] [PubMed] [Google Scholar]
  20. Giannini A, Burge H, Shaheen J, Price W. Khat : another drug of abuse? J Psychoactive Drugs 1986; 18(2) : 155–158. [PubMed] [Google Scholar]
  21. Alem A, Shibre T. Khat induced psychosis and its medico-legal implication : a case report. Ethiop Med J 1997; 35 : 137–139. [PubMed] [Google Scholar]
  22. Elmi A. The chewing of khat in Somalia. J Ethnopharmacol 1983; 8(2) : 163–176. [CrossRef] [PubMed] [Google Scholar]
  23. Al-Hebshi N, Skaug N. Khat (Catha edulis) : An updated review. Addict Biol 2005; 10 : 299–307. [CrossRef] [PubMed] [Google Scholar]
  24. Halket J, Karasu Z, Murray-Lyon I. Plasma cathinone levels following chewing khat leaves (Catha edulis Forsk). J Ethnopharmacol 1995; 49(2) : 111–113. [CrossRef] [PubMed] [Google Scholar]
  25. Brenneisen R, Geisshüsler S, Schorno X. Metabolism of cathinone to (-)-norephedrine and (-)-norpseudoephedrine. J Pharm Pharmacol 1986; 38 : 298–300. [CrossRef] [PubMed] [Google Scholar]
  26. Kalix P. Khat, an amphetamine-like stimulant. J Psychoactive Drugs 1994; 26 : 69–74. [CrossRef] [PubMed] [Google Scholar]
  27. Feyissa A, Kelly J. A review of the neuropharmacological properties of khat. Prog Neuro-Psychoph 2008; 32 : 1147–1166. [CrossRef] [PubMed] [Google Scholar]
  28. Wabe N. Chemistry, Pharmacology, and Toxicology of Khat (Catha Edulis Forsk) : A Review. Addict & Health 2011; 3(3-4) : 137–149. [Google Scholar]
  29. Corkery JM, Schifano F, Oyefeso A, Ghodse AH, Tonia T, Naidoo V, Button J. Overview of literature and information on "khat-related" mortality : a call for recognition of the issue and further research. Ann Ist Super Sanita 2011; 47(4) : 445–464. [PubMed] [Google Scholar]
  30. Warfa N, Klein A, Bhui K, Leavey G, Craig T, Stanfeld S. Khat use and mental illness : A critical review. Soc Sci Med 2007; 65 : 309–318. [CrossRef] [PubMed] [Google Scholar]
  31. Hassan N, Gunaid A, Murray-Lyon I. Khat (Catha edulis) : health aspects of khat chewing. East Mediterr Health J 2007; 13 : 706–718. [PubMed] [Google Scholar]
  32. Toennes SW, Kauert GF. Driving under the influence of khat-alkaloid concentrations and observations in forensic cases. Forensic Sci Int 2004; 140 : 85–90. [CrossRef] [PubMed] [Google Scholar]
  33. Eckersley W, Salmon R, Gebru M. Khat, driver impairment and road traffic injuries : a view from Ethiopia. Bull World Health Organ 2010; 88 : 235–236. [CrossRef] [PubMed] [Google Scholar]
  34. Pantelis C, Hindler C, Taylor J. Khat, toxic reactions to this substance, its similarities to amphetamine, and the implication of treatment for such patients. J Subst Abuse Treat 1989; 6 : 205–206. [CrossRef] [PubMed] [Google Scholar]
  35. Colzato L, Ruiz M, van den Wildenberg W, Hommel B. Khat use is associated with impaired working memory and cognitive flexibility. Plos ONE 2011, 6(6) : e20602 doi:10.13771/journal.pone.0020602 [CrossRef] [PubMed] [Google Scholar]
  36. Odenwald M. Chronic khat use and psychotic disorders : A review of the literature and future prospects. Sucht 2007; 53(1) : 9–22. [CrossRef] [Google Scholar]
  37. Stefan J, Mathew B. Khat chewing : an emerging drug concern in Australia? Aust NZ J Psychiatr 2005; 39 : 842–843. [CrossRef] [Google Scholar]
  38. Bimerew M, Sonn F, Kortenbout W. Substance abuse and the risk of readmission of people with schizophrenia at Amanuel Psychiatric Hospital, Ethiopia. Curationis. 2007; 30(2) : 74–81. [CrossRef] [PubMed] [Google Scholar]
  39. Alem A, Shibre T. Khat induced psychosis and its medico-legal implication : a case report. Ethiop Med J 1997; 35 : 137–139. [PubMed] [Google Scholar]
  40. Kebede D, Alem A, Mitike G, Enquselassie F, Berhane F, Abebe Y, Ayele R, Lemma W, Assefa T, Gebremichael T. Khat and alcohol use and risky sex behaviour among in-school and out-of-school youth in Ethiopia. BMC public Health 2005; 5 : 109–117. [CrossRef] [PubMed] [Google Scholar]
  41. Banjaw M, Miczck K, Schmidt W. Repeated Catha edulis administration enhances the baseline aggressive behavior in isolated rats, J Neural Transm 2006; 113 : 543–546. [CrossRef] [PubMed] [Google Scholar]
  42. Odenwald M, Neuner F, Schauer M, Elbert T, Catani C, Lingenfelter B, Hinkel H, Hafner H, Rockstroh B. Khat use as risk factor for psychotic disorders : a cross-sectional and case-control study in Somalia. BMC Medicine 2005; 3 : 5–15. [CrossRef] [PubMed] [Google Scholar]
  43. Nielen R, van der Heijden F, Tuinier S, Verhoeven W. Khat and mushrooms associated with psychosis. World J Biol Psychia 2004, 5 : 49–53. [CrossRef] [Google Scholar]
  44. Kalix P, Braenden O. Pharmacological aspects of the chewing of khat leaves. Pharmacol Rev 1985; 37(2) : 149–164. [PubMed] [Google Scholar]
  45. Hassan N, Gunaid A, El-Khally F, Al-Noami M, Murray-Lyon I. Khat chewing and arterial blood pressure. A randomized controlled clinical trial of alpha-1 and selective beta-1 adrenoceptor blockade. Saudi Med J 2005; 26 : 537–541. [PubMed] [Google Scholar]
  46. Tesfayes F, Byass P, Walls S, Berhane Y, Bonita R. Association of smoking and khat (Catha edulis Forsk) use with high blood pressure among adults in Addis Ababa, Ethiopia, 2006. Prev Chronic Dis 2008; 5, A89. [PubMed] [Google Scholar]
  47. Getahun W, Gedif T, Tesfaye F. Regular Khat (Catha edulis) chewing is associated with elevated diastolic blood pressure among adults in Butajira, Etiopia : A comparative study. BMC Public Health 2010; 10 : 390–398. [CrossRef] [PubMed] [Google Scholar]
  48. Baker K, Herbert A, Broadley K. Vasoconstriction of porcine left anterior descending coronary artery by ecstasy and cathinone is not an indirect sympathomimetic effect. Vascul Pharmacol 2007; 47 : 10–17. [CrossRef] [PubMed] [Google Scholar]
  49. Alkadi H, Noman M, Al-Thobhani A, Al-Mekhlafi F, Raja’a Y. Clinical and experimental evaluation of the effect of khat-induced myocardial infarction. Saudi Med J 2002; 23 : 1195–1198. [PubMed] [Google Scholar]
  50. Al-Motarreb A, Briancon S, Al-Jaber N, Al-Adhi B, Al-Jailani F, Salek M, Broadley K. Khat chewing is a risk factor for acute myocardial infarction : a case-control study. Br J Clin Pharmacol 2005; 59(5) : 574–581. [CrossRef] [PubMed] [Google Scholar]
  51. Ali W, Zubaid M, Al-Motarreb A, Singh R, Al-Shereiqi S, Shehab A, Rashed W, Al-Sagheer N, Saleh A, Al Suwaidi J. Association of khat chewing with increased risk of stroke and death in patients presenting with acute coronary syndrome. Mayo Clin Proc 2010; 85(11) : 974–980. [CrossRef] [PubMed] [Google Scholar]
  52. Apps A, Matloob S, Dahdal MT, Dubrey S. Khat : an emerging threat to the heart in the UK. Postgrad Med J 2011; 87(1028) : 387–388. [CrossRef] [PubMed] [Google Scholar]
  53. Mateen F, Casino G. Khat chewing : a smokeless gun? Mayo Clin Proc 2010; 85 : 971–973. [CrossRef] [PubMed] [Google Scholar]
  54. Ali W, Al Habib K, Al-Motarreb A, Singh R, Hersi A, Al Faleh H, Asaad N, Al Saif S, Almahmeed W, Sulaman K, Amin H, Al-lawati, Al Bustani N, Al-SagheerNorah Q, Al-Qahtani A, Al Suwaidi J. Acute coronary syndrome and khat herbal amphetamine use. An observational report. Circulation 2011; 13 : 2681–2689. [Google Scholar]
  55. Cornnor J, Malkonnen E, Rostom A. Comparaison of analgesic effects of Khat (Catha edulis) extract, D-amphetamine and inbuprofen in mice. J Pharm Pharmacol 2000; 52 : 107–110. [CrossRef] [PubMed] [Google Scholar]
  56. Graziani M, Milella M, Nencini P. Khat chewing from the pharmacological point of view : an update. Subst Use Misuse 2008; 43 : 762–783. [CrossRef] [PubMed] [Google Scholar]
  57. Haft J, Krantz P, Albert F, Fani K. Intravascular platelet aggregation in the heart induced by norepinephrine : microscopic studies. Circulation 1972; 46 : 698–708. [CrossRef] [PubMed] [Google Scholar]
  58. Broadley K. The vascular effects of trace amines and amphetamines, Pharmacol Therapeut 2010; 125 (3) : 363–375. [CrossRef] [Google Scholar]
  59. Mujili H, Bo X, Yhang L. The effect of Khat (Catha edulis) on acute cerebral infarction. Neuroscience 2005; 10 : 219–222. [Google Scholar]
  60. de Ridder S, Eerens F, Hofstra L. Khat rings twice : khat-induced thrombosis in two vascular territories. Neth Heart J 2007; 15 : 269–270. [PubMed] [Google Scholar]
  61. Vanwalleghem I, Vanwalleghem P, De Bleecker J. Khat chewing can cause stroke. Cerebrovasc Dis 2006; 22 : 198–200. [CrossRef] [PubMed] [Google Scholar]
  62. Al-Hadrani AM. Khat induced haemorrhoidal disease in Yemen. Saudi Med J 2000; 21 : 475–477. [PubMed] [Google Scholar]
  63. Soufi H, Kameswaran M, Malatani T. Khat and oral cancer. J Laryngol Otol 1991; 1205 : 643–645. [CrossRef] [Google Scholar]
  64. Goldenberg D, Lee J, Koch W, Kim M, Trink B, Sidransky D, Moon C. Habitual risk factors for head and neck cancer. Otolaryngol Head Neck Surg 2004; 131 : 986–993. [CrossRef] [PubMed] [Google Scholar]
  65. Kassie F, Darroudi F, Kundi M, Schulte-Hermann R, Knasmuller S. Khat (Catha edulis) consumption causes genotoxic effects in humans. Int J Cancer 2001; 92 : 329–332. [CrossRef] [PubMed] [Google Scholar]
  66. Warnakulasuriya S. Causes of oral cancer – an appraisal of controversies. Brit Dent J 2009; 207(10) : 471–475. [CrossRef] [Google Scholar]
  67. Balint E, Falkay G, Balint G. Khat – a controversial plant. Wien Klin Wochenschr 2009; 121 : 604–614. [CrossRef] [PubMed] [Google Scholar]